Apr 5, 2023
Kat Kwiatkowski, the Senior VP of Clinical Development at Strata Oncology, has tested over 60,000 patients and used their clinical outcome data to build advanced multivariate biomarkers to better predict patient response to approved cancer treatments. Using molecular profiling data, Strata has created an...
Apr 5, 2023
Kat Kwiatkowski, the Senior VP of Clinical Development at Strata Oncology, has tested over 60,000 patients and used their clinical outcome data to build advanced multivariate biomarkers to better predict patient response to approved cancer treatments. Using molecular profiling data, Strata has created an...
Feb 16, 2023
Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term...
Feb 16, 2023
Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, reflects on the impact COVID has had on our understanding that, as a society, we are only as safe as the least protected member in our global community. He emphasizes the need to diagnose pre-symptomatic and symptomatic conditions and the long-term...
Jan 31, 2023
Tuvik Beker, CEO of Pangea Biomed, is looking for more accurate biomarkers for oncology to determine better who might benefit from a specific drug. Their ENLIGHT platform is a pan-cancer, pan-treatment response predictor and can be used to find the best patient populations to give a new drug. They are also working with...